Third Opioid Treatment Medication Unit in California Opens by Aegis Treatment Centers

Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on globalbankingandfinance.com is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies Sponsored Posts etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at globalbankingandfinance.com with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. Globalbankingandfinance.com also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites. Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. A very few articles on our website are sponsored posts or paid advertorials. These are marked as sponsored posts at the bottom of each post. For avoidance of any doubts and to make it easier for you to differentiate sponsored or non-sponsored articles or links, you may consider all articles on our site or all links to external websites as sponsored . Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

Aegis Treatment Centers, the largest outpatient treatment provider in California for opioid addiction, has opened a medication unit at 1111 W. Inyokern Road, Suite B, in Ridgecrest, approximately 100 miles east of Bakersfield.

Aegis Ridgecrest is the states third med unit. The other two, also Aegis centers, are located in Grass Valley and Placerville.

Intended for rural counties and to provide ease of access, medication units are treatment facilities which administer medicine such as methadone and buprenorphine in an effort to curb withdrawal symptoms from heroin and opioid addiction; prevent relapse; and quell the physical discomfort that frequently accompanies recovery from opioid use disorder. Med units also collect urine samples for drug testing and analysis.

A medication unit is geographically separated from its home opioid treatment program (OTP), which provides the full range of medication-assisted treatment (MAT) services including individual and group counseling. Aegis home OTP for the Ridgecrest unit is Aegis Bakersfield Columbus.

Many of our patients at the Bakersfield Columbus location travel long distances each day for their daily dose of life-saving medication, said Javier Moreno, regional clinic manager, Aegis Treatment Centers. These are individuals who are already struggling with their addiction; we want to make their lives easier, not harder, so they can get the help they need. If we can remove one barrier, such as distance, thats one step closer we can bring them to recovery.

As the opioid crisis has spread, it has affected both urban and rural communities across the country. California saw more than 2,000 opioid deaths in 2017, according to the California Department of Public Health. In 2017, 75 people died from opioid overdoses in Kern County, an 8 percent increase from the year before. And in 2018, there were 92 deaths recorded in the county, another increase.

The location of Aegis Ridgecrest is on the border of three counties. Officials from neighboring San Bernardino County are contracting with Aegis to enable their residents to have access to the med unit as well.

Aegis operates 35 opioid treatment programs throughout California. Aegis is owned by Pinnacle Treatment Centers, a leading drug and alcohol addiction treatment services provider headquartered in New Jersey.

Pinnacle has four other medication units in Kentucky and one in Ohio, in addition to other treatment centers through the Midwest and East regions offering a full continuum of care.

Med units like this are so important as they provide a bridge to services in places where there are little to no treatment options available, added Holly Broce, MHA, LCADC, senior vice president of Pinnacles Opioid Treatment Program Division. We are ready to make a difference in this community.

Aegis Ridgecrest accepts Medical, Medicare, commercial insurance, and offers reasonable self-pay rates. The unit is open weekdays, 7- 11 a.m., and on weekends, 7- 9 a.m. Anyone needing a free confidential assessment can call 760-301-6945.

About Pinnacle Treatment Centers

Pinnacle Treatment Centers is a recognized leader in comprehensive drug and alcohol addiction treatment serving more than 28,000 patients daily in California, Indiana, Kentucky, New Jersey, Ohio, Pennsylvania, and Virginia. With more than 110 community-based locations, Pinnacle provides a full continuum of quality care for adult men and women including medically-monitored detoxification/withdrawal management, inpatient/residential treatment, partial hospitalization/care, sober living, intensive and general outpatient programming, and medication-assisted treatment (MAT) for opioid use disorder. For more information, visit pinnacletreatment.com or call 800-782-1520.

Media:

Melanie Eilers

Senior Director of Communications

Pinnacle Treatment Centers

630-806-9925

[email protected]